Digital Twins to Develop Gentler Chemotherapy for Children

Researchers are using digital twins to simulate chemotherapy treatments and reduce side effects in pediatric cancer patients.

A team of scientists is leveraging digital twins to develop more effective and gentler chemotherapy treatments for children with cancer. The digital replicas of pediatric patients are being used to simulate various treatment scenarios and predict potential side effects. This approach aims to minimize harm and improve treatment outcomes for young patients.

The digital twins are created using data from real patients, including their medical history, genetic profiles, and treatment responses. This information is used to build a virtual representation of the patient, which can be simulated and tested in a controlled environment.

The goal is to tailor chemotherapy treatments to individual patients, reducing the risk of severe side effects and improving their quality of life during treatment.